SEC 13F Intelligence

Carlson Capital, L.P. / ALXN

Carlson Capital, L.P.’s Alexion Pharmaceuticals Inc Position

Does Carlson Capital, L.P. own Alexion Pharmaceuticals Inc (ALXN)? Not currently — the last reported position was 679.1K shares worth $125M in Q2 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$125M
Q2 2021
Shares
679.1K
% of Portfolio
+6.02%
Quarters Held
3
position exited

Position History ALXN

Reported value by quarter
Q4 ’20: $76MQ4 ’20Q1 ’21: $94MQ1 ’21Q2 ’21: $125MQ2 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2021679.1K$125M+6.02%
Q1 2021613.4K$94M+3.49%
Q4 2020485.0K$76M+2.70%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Carlson Capital, L.P.’s full portfolio or all institutional holders of ALXN.